-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Pharma-Bio Serv, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Pharma-Bio Serv, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$382K, a 183% decline year-over-year.
- Pharma-Bio Serv, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$1.19M, a 189% decline year-over-year.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2023 was $1.12M, a 4.9% decline from 2022.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2022 was $1.17M.
- Pharma-Bio Serv, Inc. annual Operating Income (Loss) for 2021 was -$3.85M, a 273% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)